Acetyl Dipeptide-3 Aminohexanoate
Description
Acetyl Dipeptide-3 Aminohexanoate is the reaction product of acetic acid and Dipeptide-3 with 6-aminohexanoic acid
Function
Properties
Regulatory Status
Acetyl Dipeptide-3 Aminohexanoate (Bodyfensine, Lubrizol Life Science) is a proprietary synthetic peptide functioning as a skin conditioning agent via stimulation of human beta-defensins hBD-2 and hBD-3, supporting innate antimicrobial skin defense. Not listed in EU Annex II, III, IV, V, or VI — permitted under general provisions of Regulation (EC) 1223/2009. No SCCS opinion issued. No CIR review completed. No FDA restrictions; reported under MoCRA as a cosmetic ingredient. Very low use levels (0.005-0.05%) and peptide hydrolysis read-across are the primary safety arguments available. Formulators must request full toxicology package from supplier. Add below 40°C at final manufacturing stage.
No FDA monograph entry or specific restriction applies to Acetyl Dipeptide-3 Aminohexanoate. Not a sunscreen active. Under MoCRA, this ingredient would be disclosed in product listings with no special restrictions beyond general cosmetic GMP requirements. No CIR safety assessment has been completed for this specific ingredient. VCRP usage data not publicly confirmed for this peptide.